Eyenovia, Inc. (EYEN) Financial Statements (2024 and earlier)

Company Profile

Business Address 295 MADISON AVENUE,
NEW YORK, NY 10017
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17,46818,46622,86417,39921,50726,716
Cash and cash equivalents17,46818,46622,86417,39921,50726,716
Restricted cash and investments    7,875  
Inventory, net of allowances, customer advances and progress billings      
Inventory      
Prepaid expense601803228455725966
Deposits current assets  120120   
Other undisclosed current assets5,2085,5354,4323,6883,3822,717
Total current assets:23,27724,92427,64329,41725,61330,399
Noncurrent Assets
Operating lease, right-of-use asset1,9151,5081,292   
Property, plant and equipment3,6982,1531,2951,3431,4071,370
Intangible assets, net (including goodwill)      
Intangible assets, net (excluding goodwill)      
Restricted cash and investments     7,8757,875
Other undisclosed noncurrent assets457724807646712544
Total noncurrent assets:6,0704,3853,3941,9889,9939,789
TOTAL ASSETS:29,34729,30931,03631,40535,60640,188
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,3131,4023,1801,1052,6872,332
Interest and dividends payable118
Employee-related liabilities675
Accounts payable1,3131,4021,4281,1052,6871,535
Accrued liabilities   1,752  3
Debt9471,2193497,2297,4297,740
Deferred rent credit    292724
Other undisclosed current liabilities1,8042,2809842,6531,838283
Total current liabilities:4,0644,9014,51211,01611,98210,379
Noncurrent Liabilities
Liabilities, other than long-term debt1,5841,134908611415
Deferred rent credit    611415
Operating lease, liability1,5841,134908   
Other undisclosed noncurrent liabilities13,1777,4618,382   
Total noncurrent liabilities:14,7618,5959,290611415
Total liabilities:18,82513,49613,80211,07611,99510,394
Equity
Equity, attributable to parent, including:10,52215,81417,23520,32923,61129,794
Common stock444433
Treasury stock, value(4,494)(15,911)    
Additional paid in capital140,704139,780135,461132,433128,405127,350
Accumulated deficit(130,186)(123,970)(118,230)(112,107)(104,798)(97,559)
Other undisclosed equity, attributable to parent4,49415,911    
Total equity:10,52215,81417,23520,32923,61129,794
TOTAL LIABILITIES AND EQUITY:29,34729,30931,03631,40535,60640,188

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues      
Cost of revenue      
Operating expenses(5,961)(5,459)(5,372)(7,230)(7,121)(7,188)
Other undisclosed operating income      
Operating loss:(5,961)(5,459)(5,372)(7,230)(7,121)(7,188)
Nonoperating income (expense)119711017033(7)
Other nonoperating income (expense)119711017033(7)
Interest and debt expense(558)(454)(904)(177)(153)(145)
Loss from continuing operations:(6,399)(5,842)(6,176)(7,337)(7,242)(7,340)
Loss before gain (loss) on sale of properties:(7,337)(7,242)(7,340)
Net loss:(6,399)(5,842)(6,176)(7,337)(7,242)(7,340)
Other undisclosed net income attributable to parent184102532820
Net loss available to common stockholders, diluted:(6,216)(5,739)(6,123)(7,309)(7,239)(7,340)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(6,399)(5,842)(6,176)(7,337)(7,242)(7,340)
Comprehensive loss, net of tax, attributable to parent:(6,399)(5,842)(6,176)(7,337)(7,242)(7,340)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: